NCNMGF
TRLV

Nano-Cap New Millennium Growth Fund’s Trulieve Cannabis Corp TRLV Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio TRLV Stock Details TRLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$812K Buy
145,000
+32,500
+29% +$182K 0.76% 48
2025
Q4 		$978K Buy
+112,500
New +$978K 0.83% 43

Other funds holding TRLV

ADMI
Albert D. Mason Inc Boston, Massachusetts $154M AUM 25.1% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's TRLV Position: Q1 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Trulieve Cannabis Corp (TRLV) stake by 29% in Q1 2026, buying an estimated $182K and bringing the position to 145,000 shares worth $812K. The position accounts for 0.76% of the portfolio, ranked #48.

Nano-Cap New Millennium Growth Fund first reported a position in TRLV in Q4 2025 and has held it in 2 quarters since. The position peaked at $978K in Q4 2025. 6 funds tracked by Wall St. Rank hold TRLV as of Q1 2026.

  • Nano-Cap New Millennium Growth Fund held 145,000 shares of Trulieve Cannabis Corp worth $812K as of Q1 2026.
  • Nano-Cap New Millennium Growth Fund bought 32,500 Trulieve Cannabis Corp shares in Q1 2026, an estimated $182K.
  • Trulieve Cannabis Corp made up 0.76% of Nano-Cap New Millennium Growth Fund's portfolio in Q1 2026, its #48 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Trulieve Cannabis Corp in Q4 2025 and has held it in 2 quarters since.
  • Nano-Cap New Millennium Growth Fund's Trulieve Cannabis Corp position peaked at $978K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q1 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q1 2026, filed 15 May 2026.